# Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity

> **NCT03941184** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 114 (actual)

## Conditions studied

- SCAD
- Addison Disease
- Ankylosing Spondylitis
- Antiphospholipid Antibody Syndrome
- Celiac Disease
- Crohn Disease
- Dermatomyositis
- Polymyositis
- Guillain-Barre Syndrome
- Hepatitis, Autoimmune
- Graves Disease
- Hashimoto Thyroiditis
- Multiple Sclerosis
- Myasthenia Gravis
- Pernicious Anemia
- Polymyalgia Rheumatica
- Primary Biliary Cirrhosis
- Psoriasis
- Rheumatoid Arthritis
- Systemic Sclerosis
- Sjögren Syndrome
- Systemic Lupus Erythematosus
- Takayasu Arteritis
- Type 1 Diabetes Mellitus
- Ulcerative Colitis
- Uveitis
- Vasculitis
- Vitiligo
- Raynaud

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03941184
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1995-01-01
- **Primary completion:** 2020-11-10
- **Final completion:** 2020-11-10
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2020-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03941184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03941184, "Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03941184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*